Contact Us
Subscribe
E-Edition

40°

Site search

Open user controls
- Log In Using Your Account
  Log In
  
  Don't have an account? Sign Up Today

- My Account
- Dashboard
- Profile
- Saved items
- Logout

Home
News
Sports
Obits
Multimedia
- Photo Galleries
- Videos
e-Edition
Classifieds
Subscribe
Archives
Best of 2025
Pet Contest

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Cytokinetics, Incorporated - Common Stock (NQ:CYTK)

63.83 +2.46 (+4.00%)

Streaming Delayed Price Updated: 10:54 AM EST, Dec 31, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Cytokinetics, Incorporated - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

Potential Takeover In Works for Cardiovascular Treatment Focused Cytokinetics ↗

November 01, 2023

Cytokinetics Inc (NASDAQ: CYTK), a late-stage biotech company focused on cardiovascular treatments, is reportedly exploring potential takeover options as it has garnered interest from at least one...

Via Benzinga

HC Wainwright & Co. Maintains Buy Rating for Cytokinetics: Here's What You Need To Know ↗

October 20, 2023

Via Benzinga

Union Pacific To Rally Around 12%? Here Are 10 Top Analyst Forecasts For Friday ↗

October 20, 2023

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

October 10, 2023

Via Benzinga

Expert Ratings for Cytokinetics ↗

October 09, 2023

Via Benzinga

Where Cytokinetics Stands With Analysts ↗

August 22, 2023

Via Benzinga

Where Cytokinetics Stands With Analysts ↗

August 04, 2023

Via Benzinga

11 Analysts Have This to Say About Cytokinetics ↗

June 20, 2023

Via Benzinga

Why CalAmp Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

October 06, 2023

Gainers

Via Benzinga

NuScale Power, Stagwell And Other Big Stocks Moving Higher On Friday ↗

October 06, 2023

U.S. stocks traded higher, with the Nasdaq Composite gaining around 50 points on Friday. Here are some big stocks recording gains in Friday's session.

Via Benzinga

Topics Stocks

What 20 Analyst Ratings Have To Say About Cytokinetics ↗

May 22, 2023

Via Benzinga

18 Analysts Have This to Say About Cytokinetics ↗

May 05, 2023

Via Benzinga

Cytokinetics: Q1 Earnings Insights ↗

May 04, 2023

Via Benzinga

Analyst Ratings for Cytokinetics ↗

April 18, 2023

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

October 05, 2023

Via Benzinga

The 3 Best Mid-Cap Stocks to Buy Now: September 2023 ↗

September 07, 2023

With the best mid-cap stocks to buy, investors get the best of both worlds: an established business but with ample room to grow.

Via InvestorPlace

10 Health Care Stocks With Whale Alerts In Today's Session ↗

September 05, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 15, 2023 ↗

August 15, 2023

Via Benzinga

Analyst Expectations for Cytokinetics's Future ↗

March 31, 2023

Via Benzinga

Analyst Ratings for Cytokinetics ↗

March 06, 2023

Via Benzinga

FDA Rejects Cytokinetics' Heart Failure Treatment Candidate ↗

March 01, 2023

Via Benzinga

Atlassian, Universal Display, Booking, Dropbox And Other Big Stocks Moving Higher On Friday ↗

August 04, 2023

U.S. stocks traded higher, with the Dow Jones gaining around 150 points on Friday. Here are some big stocks recording gains in today’s session.

Via Benzinga

5 Biotech Stocks That Could Soar Thanks To These Disruptive Healthcare Technologies ↗

June 20, 2023

Via Benzinga

Cytokinetics Plans To Discontinue Late-Stage ALS Trial Due To Futility ↗

March 31, 2023

Cytokinetics Incorporated (NASDAQ: CYTK) announced that the Data Monitoring Committee (DMC) for COURAGE-ALS recently convened to conduct the second planned interim analysis of this Phase 3 clinical...

Via Benzinga

Earnings Scheduled For March 1, 2023 ↗

March 01, 2023

Companies Reporting Before The Bell • Globalstar (AMEX:GSAT) is expected to report quarterly loss at $0.01 per share on revenue of $38.75 million.

Via Benzinga

Cytokinetics's Earnings: A Preview ↗

February 28, 2023

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

July 26, 2023

Wednesday saw 59 companies set new 52-week lows.

Via Benzinga

Cytokinetics Posts Aficamten Data In Patients With Thickened Heart Muscle ↗

March 06, 2023

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

July 24, 2023

On Monday morning, 70 companies achieved new lows for the year.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For February 17, 2023 ↗

February 17, 2023

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

Home
News
Sports
Entertainment
Local Events
Obituaries
Multimedia
e-Edition
Online Features

Services

Subscription Services
Submission Forms
Classifieds
Place an Ad
Promote Your Event
Email Alerts
Search
Weather

starkvilledailynews.com
304 E. Lampkin Street,
Starkville, MS 39759
Phone: 662-323-1642
Email: editor@starkvilledailynews.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Log In Using Your Account

Cytokinetics, Incorporated - Common Stock (NQ:CYTK)

Headline News about Cytokinetics, Incorporated - Common Stock

Sections

Services

Follow Us